HPTN 084-01

HPTN 084-01 (The LIFT Study) is a clinical trial examining whether injectable cabotegravir (CAB LA) for PrEP  (pre-exposure prophylaxis) is safe and acceptable for adolescents assigned female at birth. We would also like to look at the tolerability, or side effects, of CAB. 

This study is a collaboration between the HIV Prevention Trials Network (HPTN), the Bill and Melinda Gates Foundation (BMGF), and ViiV Healthcare.